Page last updated: 2024-10-31

nafamostat and Influenza, Human

nafamostat has been researched along with Influenza, Human in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Si, L1
Bai, H1
Oh, CY1
Jin, L1
Prantil-Baun, R1
Ingber, DE1
Sato, K1
Hayashi, H1
Shimotai, Y1
Yamaya, M1
Hongo, S1
Kawakami, K1
Matsuzaki, Y1
Nishimura, H1

Other Studies

2 other studies available for nafamostat and Influenza, Human

ArticleYear
Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip.
    Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2

    Topics: Amantadine; Antiviral Agents; Benzamidines; Drug Resistance, Viral; Evolution, Molecular; Guanidines

2021
TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.
    Journal of virology, 2021, 10-13, Volume: 95, Issue:21

    Topics: Amino Acid Sequence; Animals; Antiviral Agents; Benzamidines; Cell Line; Cell Line, Tumor; Cells, Cu

2021